126 related articles for article (PubMed ID: 29980182)
1. Targeting HOX-PBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes.
Platais C; Radhakrishnan R; Niklander Ebensperger S; Morgan R; Lambert DW; Hunter KD
BMC Cancer; 2018 Jul; 18(1):723. PubMed ID: 29980182
[TBL] [Abstract][Full Text] [Related]
2. Targeting HOX/PBX dimer formation as a potential therapeutic option in esophageal squamous cell carcinoma.
Shen LY; Zhou T; Du YB; Shi Q; Chen KN
Cancer Sci; 2019 May; 110(5):1735-1745. PubMed ID: 30844117
[TBL] [Abstract][Full Text] [Related]
3. HOX transcription factors are potential targets and markers in malignant mesothelioma.
Morgan R; Simpson G; Gray S; Gillett C; Tabi Z; Spicer J; Harrington KJ; Pandha HS
BMC Cancer; 2016 Feb; 16():85. PubMed ID: 26867567
[TBL] [Abstract][Full Text] [Related]
4. Targeting the HOX/PBX dimer in breast cancer.
Morgan R; Boxall A; Harrington KJ; Simpson GR; Gillett C; Michael A; Pandha HS
Breast Cancer Res Treat; 2012 Nov; 136(2):389-98. PubMed ID: 23053648
[TBL] [Abstract][Full Text] [Related]
5. Targeting HOX and PBX transcription factors in ovarian cancer.
Morgan R; Plowright L; Harrington KJ; Michael A; Pandha HS
BMC Cancer; 2010 Mar; 10():89. PubMed ID: 20219106
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells.
Alharbi RA; Pandha HS; Simpson GR; Pettengell R; Poterlowicz K; Thompson A; Harrington K; El-Tanani M; Morgan R
Oncotarget; 2017 Oct; 8(52):89566-89579. PubMed ID: 29163771
[TBL] [Abstract][Full Text] [Related]
7. Targeting HOX transcription factors in prostate cancer.
Morgan R; Boxall A; Harrington KJ; Simpson GR; Michael A; Pandha HS
BMC Urol; 2014 Feb; 14():17. PubMed ID: 24499138
[TBL] [Abstract][Full Text] [Related]
8. The highest affinity DNA element bound by Pbx complexes in t(1;19) leukemic cells fails to mediate cooperative DNA-binding or cooperative transactivation by E2a-Pbx1 and class I Hox proteins - evidence for selective targetting of E2a-Pbx1 to a subset of Pbx-recognition elements.
Knoepfler PS; Kamps MP
Oncogene; 1997 May; 14(21):2521-31. PubMed ID: 9191052
[TBL] [Abstract][Full Text] [Related]
9. Potential role of hematopoietic pre-B-cell leukemia transcription factor-interacting protein in oral carcinogenesis.
Okada S; Irié T; Tanaka J; Yasuhara R; Yamamoto G; Isobe T; Hokazono C; Tachikawa T; Kohno Y; Mishima K
J Oral Pathol Med; 2015 Feb; 44(2):115-25. PubMed ID: 25060351
[TBL] [Abstract][Full Text] [Related]
10. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
Calvo KR; Knoepfler P; McGrath S; Kamps MP
Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
[TBL] [Abstract][Full Text] [Related]
11. Conformational changes in the PBX homeodomain and C-terminal extension upon binding DNA and HOX-derived YPWM peptides.
Sprules T; Green N; Featherstone M; Gehring K
Biochemistry; 2000 Aug; 39(32):9943-50. PubMed ID: 10933814
[TBL] [Abstract][Full Text] [Related]
12. Specific residues in the Pbx homeodomain differentially modulate the DNA-binding activity of Hox and Engrailed proteins.
Peltenburg LT; Murre C
Development; 1997 Mar; 124(5):1089-98. PubMed ID: 9056783
[TBL] [Abstract][Full Text] [Related]
13. Residues flanking the HOX YPWM motif contribute to cooperative interactions with PBX.
Shanmugam K; Featherstone MS; Saragovi HU
J Biol Chem; 1997 Jul; 272(30):19081-7. PubMed ID: 9228093
[TBL] [Abstract][Full Text] [Related]
14. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 7 agonist, imiquimod, inhibits oral squamous carcinoma cells through apoptosis and necrosis.
Ahn MY; Kwon SM; Cheong HH; Park JH; Lee J; Min SK; Ahn SG; Yoon JH
J Oral Pathol Med; 2012 Aug; 41(7):540-6. PubMed ID: 22577802
[TBL] [Abstract][Full Text] [Related]
16. Targeting HOX/PBX dimers in cancer.
Morgan R; El-Tanani M; Hunter KD; Harrington KJ; Pandha HS
Oncotarget; 2017 May; 8(19):32322-32331. PubMed ID: 28423659
[TBL] [Abstract][Full Text] [Related]
17. The Pbx family of proteins is strongly upregulated by a post-transcriptional mechanism during retinoic acid-induced differentiation of P19 embryonal carcinoma cells.
Knoepfler PS; Kamps MP
Mech Dev; 1997 Apr; 63(1):5-14. PubMed ID: 9178252
[TBL] [Abstract][Full Text] [Related]
18. A Computer-Based Methodology to Design Non-Standard Peptides Potentially Able to Prevent HOX-PBX1-Associated Cancer Diseases.
Gulotta MR; De Simone G; John J; Perricone U; Brancale A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073517
[TBL] [Abstract][Full Text] [Related]
19. Pbx raises the DNA binding specificity but not the selectivity of antennapedia Hox proteins.
Neuteboom ST; Murre C
Mol Cell Biol; 1997 Aug; 17(8):4696-706. PubMed ID: 9234726
[TBL] [Abstract][Full Text] [Related]
20. Expression of long noncoding RNA-HOX transcript antisense intergenic RNA in oral squamous cell carcinoma and effect on cell growth.
Wu J; Xie H
Tumour Biol; 2015 Nov; 36(11):8573-8. PubMed ID: 26036760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
